Press Releases Detail

Global Biopreservation Market

avatar/IMG-10 by Foreclaro Global Research
2026 Mar, 04

According to the Foreclaro Global Research, the Global Biopreservation Market size was valued at USD 2.85 billion in 2025. The report “Global Biopreservation Market Segmentation By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery)- Industry Trends and Forecast to 2033” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global biopreservation market is experiencing robust growth, driven by the rising need for safe and long-term storage of biological materials such as cells, tissues, blood products, vaccines, and stem cells. Advanced biopreservation technologies, including cryopreservation, freeze-drying, vitrification, and controlled rate freezing, help maintain the integrity, viability, and functionality of sensitive biomaterials, supporting applications in regenerative medicine, biobanking, and drug discovery. Increasing investments in life sciences research, the growing prevalence of chronic and infectious diseases, and stringent regulatory standards for biosafety and sample storage are key market drivers. North America and Europe dominate due to well-established research infrastructure, advanced healthcare facilities, and regulatory compliance, while Asia-Pacific is emerging rapidly with expanding laboratory networks, biobanking initiatives, and growing awareness of preservation technologies. Overall, the market’s growth is fueled by technological advancements, rising adoption across research and clinical sectors, and the critical need for reliable, long-term biological material storage.

 

Have any questions or need more information? Click the link below to request a sample or make an inquiry before making your purchase:

https://foreclaroglobalresearch.com/research-report/global-biopreservation-market

 

Global Biopreservation Market Report Highlights

·       Increasing demand for safe, long-term storage of cells, tissues, vaccines, and other biological materials is driving market expansion.

·       Cryopreservation, freeze-drying, vitrification, and controlled rate freezing enhance sample integrity and operational efficiency.

·       Key products include biopreservation equipment, cryoprotective media, and laboratory information management systems (LIMS).

·       Major applications include regenerative medicine, biobanking, and drug discovery, with rising adoption in clinical and research settings.

·       North America and Europe dominate due to advanced infrastructure and regulatory frameworks, while Asia-Pacific is the fastest-growing region.

·       Emerging markets, growing biobanking initiatives, and integration of automated storage solutions present growth potential, while high costs and technical complexity remain key challenges.

 

Foreclaro Global Research has segmented the Biopreservation Market report based on Product, Application, and region:

 

Biopreservation Market, Product Outlook (Revenue - USD Million, 2020 - 2033)

Equipment

Media

LIMS

 

Biopreservation Market, Application Outlook (Revenue - USD Million, 2020 - 2033)

Regenerative Medicine

Bio-banking

Drug Discovery

 

Biopreservation Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

·         United States

·         Canada

·         Mexico

 

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

 

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

 

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

 

Middle East & Africa

·         Saudi Arabia

·         South Africa

·         Rest of MEA

 

Global Biopreservation Market Key Players

·         Thermo Fisher Scientific Inc.

·         BioLife Solutions, Inc

·         Chart Industries, Inc. (Cryoport Systems)

·         Merck KGaA

·         VWR International, LLC (part of Avantor)

·         Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)

·         Brooks Life Sciences (now part of Azenta Life Sciences)

·         Biocision, LLC

·         Lifeline Scientific, Inc.

·         Cesca Therapeutics Inc.